Race Oncology Limited (RAONF)
OTCMKTS
· Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Jul 11, 2024
Race Oncology Statistics
Total Valuation
Race Oncology has a market cap or net worth of 148.80 million. The enterprise value is 138.09 million.
Market Cap | 148.80M |
Enterprise Value | 138.09M |
Important Dates
The next estimated earnings date is Sunday, February 23, 2025.
Earnings Date | Feb 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +2.35% |
Shares Change (QoQ) | +1.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 120.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 14.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -14.98 |
EV / Sales | 55.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.32
Current Ratio | 9.32 |
Quick Ratio | 9.26 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.10% and return on invested capital (ROIC) is -41.34%.
Return on Equity (ROE) | -63.10% |
Return on Assets (ROA) | -38.63% |
Return on Capital (ROIC) | -41.34% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.17 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.86% in the last 52 weeks. The beta is 1.74, so Race Oncology's price volatility has been higher than the market average.
Beta (5Y) | 1.74 |
52-Week Price Change | -15.86% |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 3,442 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Race Oncology had revenue of 2.67 million and -9.22 million in losses. Loss per share was -0.06.
Revenue | 2.67M |
Gross Profit | 927,352 |
Operating Income | -9.66M |
Pretax Income | -9.22M |
Net Income | -9.22M |
EBITDA | -9.48M |
EBIT | -9.66M |
Loss Per Share | -0.06 |
Balance Sheet
Cash & Cash Equivalents | 11.47M |
Total Debt | n/a |
Net Cash | 11.47M |
Net Cash Per Share | n/a |
Equity (Book Value) | 12.22M |
Book Value Per Share | 0.07 |
Working Capital | 10.37M |
Cash Flow
Operating Cash Flow | -6.37M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 34.72% |
Operating Margin | -361.80% |
Pretax Margin | -345.18% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Race Oncology does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.35% |
Shareholder Yield | -2.35% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Race Oncology has an Altman Z-Score of 52.36.
Altman Z-Score | 52.36 |
Piotroski F-Score | n/a |